ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,796.19
-0.03%
Gold vs US Dollar
2,423.195
-0.14%
Brent Oil
82.825
-0.84%
Bitcoin
69,612.52
-2.57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Micro Therapeutics (MM) (MTIX)

  7. Micro Therapeutics (MM) (MTIX) News

Micro Therapeutics (MTIX)

Micro Therapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MTIX
DateTimeSourceHeadlineSymbolCompany
08/12/200516:01PR Newswire (US)ev3 Inc. Announces Expected Closing Date for Acquisition of Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
14/11/200514:11PR Newswire (US)ev3 Inc. and Micro Therapeutics, Inc. Announce Merger AgreementNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200514:01PR Newswire (US)Micro Therapeutics Reports 72% Increase in 2005 Third Quarter Net SalesNASDAQ:MTIXMicro Therapeutics (MM)
27/10/200514:00PR Newswire (US)ev3 Inc. Reports Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
21/10/200515:00PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Third-Quarter Financial Results and Host Joint Conference Call on October 27, 2005NASDAQ:MTIXMicro Therapeutics (MM)
10/10/200515:30PR Newswire (US)ev3 Inc. Proposes to Acquire Public Minority Stake in Micro Therapeutics, Inc.NASDAQ:MTIXMicro Therapeutics (MM)
10/10/200514:30PR Newswire (US)Micro Therapeutics, Inc. Announces Receipt of Exchange Offer Proposal From ev3 Inc.NASDAQ:MTIXMicro Therapeutics (MM)
05/10/200519:04PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Third Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
02/08/200522:51PR Newswire (US)Micro Therapeutics Reports 44% Increase in Net Sales for 2005 Second Quarter; Company Raises Sales Guidance for 2005NASDAQ:MTIXMicro Therapeutics (MM)
02/08/200522:48PR Newswire (US)ev3 Inc. Reports Second Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
27/07/200521:27PR Newswire (US)ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005NASDAQ:MTIXMicro Therapeutics (MM)
21/07/200523:27PR Newswire (US)ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
21/07/200523:08PR Newswire (US)Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular DisorderNASDAQ:MTIXMicro Therapeutics (MM)
06/07/200523:30PR Newswire (US)Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005NASDAQ:MTIXMicro Therapeutics (MM)
28/04/200522:14PR Newswire (US)Micro Therapeutics Reports 50% Net Sales Increase for 2005 First QuarterNASDAQ:MTIXMicro Therapeutics (MM)
25/04/200518:28PR Newswire (US)Micro Therapeutics to Report First Quarter Financial Results and Host Conference Call on April 28, 2005NASDAQ:MTIXMicro Therapeutics (MM)
21/03/200521:57PR Newswire (US)ev3 Announces Enrollment Has Begun for SpideRX(TM) Embolic Protection Device in Second Phase of Carotid Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
10/02/200520:23PR Newswire (US)Micro Therapeutics Reports Record Revenue in 2004 Fourth Quarter and Full Year Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
10/02/200512:45PR Newswire (US)Reminder - Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on FebruaryNASDAQ:MTIXMicro Therapeutics (MM)
07/02/200523:40PR Newswire (US)Micro Therapeutics to Report 2004 Fourth Quarter and Full Year Financial Results and Host Conference Call on February 10, 2005NASDAQ:MTIXMicro Therapeutics (MM)
01/02/200512:00PR Newswire (US)Micro Therapeutics Receives $3.7 Million PaymentNASDAQ:MTIXMicro Therapeutics (MM)
29/12/200417:13PR Newswire (US)Micro Therapeutics Consolidates Manufacturing CapabilitiesNASDAQ:MTIXMicro Therapeutics (MM)
06/12/200420:04PR Newswire (US)ev3 Receives Investigational Device Exemption for Use of SpideRX(TM) Embolic Protection Device in Clinical TrialNASDAQ:MTIXMicro Therapeutics (MM)
10/11/200414:00PR Newswire (US)ev3 International Files Lawsuit Against Distributors in Hong Kong and PhoenixNASDAQ:MTIXMicro Therapeutics (MM)
04/11/200412:00PR Newswire (US)Micro Therapeutics Reports 2004 Third Quarter Financial ResultsNASDAQ:MTIXMicro Therapeutics (MM)
01/11/200420:24PR Newswire (US)Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4NASDAQ:MTIXMicro Therapeutics (MM)
21/10/200416:47PR Newswire (US)FDA Grants Marketing Clearance to ev3 for Protege(R) GPS(TM) Long StentsNASDAQ:MTIXMicro Therapeutics (MM)
21/09/200414:01PR Newswire (US)ev3(TM) Receives 510(k) Marketing Clearance for X-SIZER(R) Thrombectomy Catheter System for Dialysis Graft UseNASDAQ:MTIXMicro Therapeutics (MM)
26/08/200417:33PR Newswire (US)ev3 Receives CE Mark Approval for Tapered Stents for Carotid Stenting ProceduresNASDAQ:MTIXMicro Therapeutics (MM)
18/08/200418:51PR Newswire (US)Micro Therapeutics Completes Issuance of Common Stock for Exchangeable NotesNASDAQ:MTIXMicro Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:MTIX

Your Recent History

LSE
TERN
Tern
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
VAL
Valirx
LSE
VAST
Vast Resources
LSE
BP.
Bp
LSE
PHE
Powerhouse Energy
LSE
GKP
Gulf Keystone Petroleum
LSE
TEK
Tekcapital
LSE
YU.
Yu
LSE
MIN
Minoan
LSE
SYME
Supply@me Capital
LSE
SOLG
Solgold
LSE
AAZ
Anglo Asian Mining
LSE
CHLL
Chill Brands
LSE
KEFI
Kefi Gold And Copper
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved